Provided by Tiger Fintech (Singapore) Pte. Ltd.

XBiotech

2.83
-0.1300-4.39%
Post-market: 2.830.00000.00%16:04 EDT
Volume:57.78K
Turnover:167.74K
Market Cap:86.28M
PE:-2.19
High:2.98
Open:2.95
Low:2.83
Close:2.96
Loading ...

Company Profile

Company Name:
XBiotech
Exchange:
NASDAQ
Establishment Date:
2005
Employees:
90
Office Location:
5217 Winnebago Lane,Austin,Texas,United States
Zip Code:
78744
Fax:
512 386 5505
Introduction:
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Directors

Name
Position
John Simard
Founder, President, Chief Executive Officer,Chairman
Jan Paul Waldin
Lead Director
Craig Rademaker
Director
David Soffer
Director
Peter Libby
Director
Tak W. Mak
Director
Tevi D. Troy
Director
Thomas Kündig
Director

Shareholders

Name
Position
John Simard
Founder, President, Chief Executive Officer,Chairman
Angela Hu
Director of Finance
Sushma Shivaswamy
Chief Scientific Officer